chronic myeloid leukaemia - Articles and news items


NICE approves Incyte’s leukaemia drug for routine NHS use

Industry news / 13 February 2017 / Niamh Marriott, Digital Editor

NICE published draft guidance recommending ponatinib (Iclusig, Incyte Corporation) for routine use on the NHS, to treat chronic myeloid leukaemia…

Novartis wins “Discovery of the Decade” and “Best Biotechnology Product” awards

Industry news / 31 October 2016 / Niamh Louise Marriott, Digital Content Producer

Novartis has been awarded the 2016 Prix Galien USA Award “Discovery of the Decade” Award for Best Pharmaceutical Product for the drug Gleevec, as well as…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...